Long-acting injectable olanzapine can give rise to a condition consistent with central anticholinergic syndrome. [electronic resource]
Producer: 20140131Description: 2238-9 p. digitalISSN:- 0807-7096
- Anticholinergic Syndrome -- drug therapy
- Antipsychotic Agents -- administration & dosage
- Benzodiazepines -- administration & dosage
- Cholinesterase Inhibitors -- administration & dosage
- Delayed-Action Preparations
- Delirium -- chemically induced
- Humans
- Hypnotics and Sedatives -- administration & dosage
- Injections, Intramuscular
- Olanzapine
- Physostigmine -- administration & dosage
- Syndrome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.